Home
TrialShare
Member Portal
About Us
About UsMission & ValuesLeadershipNewsCareersPartnershipsSupportAchievements
For Researchers
Clinical TrialsCore FacilitiesLab ProtocolsPoliciesProposalsPublicationsTrialShareStrategic Plans
For Patients
Clinical TrialsAllergy & AsthmaAutoimmune DiseaseTransplantationType 1 DiabetesClinical Trial Info
TrialShare
Contact
Contact UsMedia Inquiries
About Us
• About Us• Mission & Values• Leadership• News• Careers• Partnerships• Support• Achievements
For Researchers
• Clinical Trials
‣ Allergy & Asthma‣ Autoimmune Disease‣ Transplantation‣ Type 1 Diabetes
• Core Facilities
• Lab Protocols
‣ ITN Protocols
• Policies
‣ Publications Policy
• Proposals
‣ Submit Proposal‣ Current RFPs‣ Past RFPs
• Publications• TrialShare
• Strategic Plans
‣ Allergy‣ Autoimmune Disease‣ Transplantation‣ Type 1 Diabetes
For Patients
• Clinical Trials• Allergy & Asthma• Autoimmune Disease
• Transplantation
‣ Kidney‣ Liver
• Type 1 Diabetes• Clinical Trial Info
TrialShare
Contact
• Contact Us
‣ BRI - Seattle Office‣ UCSF - San Francisco Office
• Media Inquiries
About UsMission & ValuesLeadershipNewsCareersPartnershipsSupportAchievements

E. John Wherry, PhD

Director, Institute for Immunology

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

The Immune Tolerance Network and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

Home
Sponsors
Careers
Contact
Search

© 2024 Immune Tolerance Network

PrivacyTerms of UseAccessibility